Loading...
Pediatrix Q1 2025 Earnings Report
Pediatrix Medical Group reported its first quarter 2025 financial results, showing an increase in net income and adjusted EBITDA compared to the prior year.
Key Takeaways
Pediatrix Medical Group reported strong first quarter 2025 results with net revenue of $458.4 million, net income of $20.7 million, and adjusted EBITDA of $49.2 million. The company raised its full-year 2025 Adjusted EBITDA outlook range to $220 million to $240 million.
Net revenue for Q1 2025 was $458.4 million, a decrease from $495.1 million in the prior-year period, primarily due to non-same unit activity.
Net income for Q1 2025 increased significantly to $20.7 million ($0.24 per diluted share) from $4.0 million ($0.05 per diluted share) in Q1 2024.
Adjusted EBITDA for Q1 2025 was $49.2 million, up from $37.2 million in the prior-year period, driven by same-unit results and practice disposition activity.
The company raised its full-year 2025 Adjusted EBITDA outlook to a range of $220 million to $240 million, reflecting strong first-quarter performance.
Forward Guidance
Pediatrix Medical Group is raising its full-year 2025 Adjusted EBITDA outlook based on strong first-quarter performance.
Positive Outlook
- Strong first quarter results exceeded expectations.
- Same-unit top-line outperformance contributed positively.
- Continued steady cost management supported the outlook.
- Successful portfolio restructuring completed last year is yielding benefits.
- Commitment to delivering value for stakeholders is reinforced by the raised guidance.
Challenges Ahead
- Uncertainty in the broader healthcare industry remains a concern.
- Broad economic turbulence continues to challenge virtually all companies.
- The company acknowledges potential risks related to its revenue cycle management transition.
- Impacts of surprise billing legislation could affect future results.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...